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Introduction
With the elderly population in lower and middle income
countries (LAMIC) predicted to increase from 60% in 2001 to
71% by 2040, dementia rates are expected to increase between
100% to 300% in these regions.1 Dementia costs for Africa have
been conservatively estimated to be in the region of US$2.9
billion.2 To address this financial and clinical burden in lower and
middle income countries, data on the local prevalence of
dementia and its associated risk factors are important. In the
absence of disease-modifying pharmacotherapeutic options,
decreasing the prevalence of dementia may be achieved by
modifying risk factors or lifestyle.3 Therefore the early
identification and management of risk factors and early
diagnosis of dementia, can contribute to a reduction in the
burden of disease and result in significant cost savings.4
While dementia is a huge public health challenge in high
income countries (HIC), with high prevalence rates reported5,6,
it appears that the prevalence may be lower in LAMIC.7 Large
prevalence studies conducted in Nigeria8 and India9 reported
figures of 2.29% and 0.84% respectively. In two large cross-
country studies, one comparing African and American Blacks8
and the other comparing rural populations from India and
America9, it was found that the prevalence rates of dementia
and Alzheimer’s Dementia (AD) were significantly lower for
participants in the lower income countries. Similar findings
have emerged from prevalence studies in Latin America and
China.7 The lower prevalence rates in LAMIC has also been
confirmed in the Delphi consensus study suggesting that
factors such as methodology, differential survival rates and/ or
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differences in the risk profile (low levels of cardiovascular risk
and hypolipidaemia) in LAMIC populations may be
contributing to the lower rates.1
While the incidence and prevalence of dementia have
been extensively studied in Western and European countries5
there remains a dearth of similar studies from Africa. The few
studies conducted in Africa prior to 2000 used small samples
and was reported to have used ‘non-standardised clinical
assessments’.10 Recent studies from Africa reported
prevalence figures ranging from 2.6% to 8.1%.11,12,13 Dementia
studies from South Africa include a Western Cape sample of
coloured people14, with a prevalence of 8.6%, and a Free State
sample of indigenous Sotho-speaking elderly black people15,
which reported a prevalence of 7.7%. 
This paper describes the clinical and risk profile of a
sample of elderly participants who were assessed for the
presence of dementia and MCI. In addition, the value of
functional assessments and subjective memory complaints in
case-finding are also explored. 
Method
The study consisted of three stages: 1) Administration of
dementia screening tools; 2) Clinical diagnostic evaluation for
dementia; and 3) Administration of a neuropsychological
battery of tests. 
Sample
The study population comprised residents (N=1450) of a
group of homes for the elderly in Durban, KwaZulu-Natal,
South Africa. The homes are administered by a non-
governmental organisation (NGO) and cater for frail care,
assisted and independent living people 60 years and older. 
An initial conveniently selected sample (n=302) was
selected to undergo screening for cognitive impairment using
the Mini-Mental State Examination (MMSE). Inclusion criteria
were: residents who were 60 years and older, a minimum of 8
years of formal schooling, the ability to speak, read and write
in English and the ability to give written, informed consent.
Exclusion criteria were: residents with severe physical, mental
or sensory handicaps that precluded their engagement in the
assessment procedures. 
This paper describes the results of the second stage of the
study, the clinical diagnostic evaluation for dementia. The
target population for this stage was 51 participants who
screened positive (<23) on the MMSE and a random selection
of the 251 participants who screened negative. The resulting
sample of 140 participants included 38 screen positives (13
either refused or were unavailable) and 102 screen negatives.
Evaluations
Clinical diagnostic evaluations were conducted in English by
three psychiatrists, who were blinded to the results of the
screening stage. A standardised clinical assessment tool was
developed for the study. The assessment tool included the
following sections: a historical review of the participant’s
cognitive status, a review of the medical, surgical, family,
medication and substance use history, a review of social and
functional activities, a physical (including neurological)
examination and a comprehensive mental state examination.
The assessment of functional abilities was based on
participant self-report as the residential setting precluded
access to informants. Participants were classified as being
functionally unable to perform specified activities of daily
living (ADL) and instrumental activities of daily living (IADL)
tasks only after medical causes for the inability were excluded.
Content validity was based on the the Diagnostic and
Statistical Manual, Fourth edition, Text Revised (DSM IV-TR)
criteria for Dementia, Major Depression and Delirium. Face
validity of the tool was established through review of the tool
by a group of psychiatrists, neurologists and psychologists.
Although the assessing psychiatrists underwent intensive
training in order to standardise the assessments, inter-rater
reliability was not formally established. 
Diagnosis
Following the clinical diagnostic assessments, a consensus
panel consisting of a senior neurologist, senior clinical
psychologist and psychiatrist assigned diagnoses of dementia,
major depression-current and delirium according to DSM IV-
TR criteria.16 Participants who did not fulfil the criteria for
dementia or MCI were categorised as ‘non-cases’. A DSM-IV-
TR16 diagnosis of dementia is based on, firstly, the
development of multiple cognitive deficits manifested by both
memory impairment as well as one of four areas (aphasia,
apraxia, agnosia, executive functioning) of cognitive
disturbances; and secondly, these cognitive deficits should
also cause significant impairment in social or occupational
functioning.16 Sub-typing of the dementias was not done. A
diagnosis of Mild Cognitive Impairment (MCI) was based on
the recommendations of the International Working Group on
Mild Cognitive Impairment and requires the presence of
subjective cognitive impairment (self or informant reported),
objective evidence of cognitive impairment in the presence of
high scores for ADL and normal or minimally-impaired IADL
functions.17 MCI diagnostic subtypes of amnestic MCI, single
domain (aMCIsd), multi-domain (aMCImd) non-amnestic MCI
single domain (naMCIsd) were based on the presence or
absence of amnesia and the presence of single or multiple
cognitive domains of impairment.18 Those participants who did
not meet criteria for Dementia or MCI were classified as non-
cases.
Investigations
For ethical reasons, all participants who were assigned a
clinical diagnosis of dementia were offered blood tests (full
blood count [FBC], blood glucose, thyroid functioning test
[TFT], syphilis serology [RPR] and Vitamin B12 and folate
levels) as well as a CT scan of the brain, without contrast. 
Statistical Analysis
The data was analysed according to diagnostic categories of
dementia and MCI. Differences in age and education between
the diagnostic groups were tested using Independent Samples
Kruskall Wallis Tests. Associations between diagnostic
categories and demographic variables, the presence of risk
factors and retained functionality in IADL were tested using
Pearsons’ Chi square Test or Fisher Exact Tests (where sample
sizes were small). Significance was set as p<.05. 
Ethics
The study received ethical approval from the Biomedical
Research Ethics Committee of the University of KwaZulu-Natal.
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Results
Demographic details
Of the 140 participants assessed, 97 (69.3%) were female and
43 (30.7%) were male. The average age of the participants was
75.2 years (± 8.9). In South Africa, four racial groups are
recognized viz Asian (Indian), black, coloured and white.
There were 65 (46.4%) white, 41 (29.3%) coloured, 28 (20%)
Asian and 6 (4.3%) black participants. Proficiency in English
was an inclusion criterion for the study. It was the first
language for 123 (87.9%) of the participants, followed by
Xhosa (7%), then Afrikaans (4.3%) and isiZulu (4.3%), and
other languages (2.9%). Eleven (7.9%) participants had more
than 12 years of education and 106 (75.7%) had less than 12
years of education. 
Most participants (132, 94.3%) were in independent living
residences with seven (5%) in assisted living. One hundred and
four (72.9%) reported that they lived alone and 32 (22.9%)
were either living together or married. A government pension
was the sole source of income for ninety-seven (69.3%)
participants. The demographic data according to the
diagnostic categories are presented in Table I. Significant
associations were found between the diagnostic categories and
the mean age and mean years of education of the participants. 
Clinical diagnostic categories
Eleven (7.9%) cases of dementia and 38 (27.1%) cases of mild
cognitive impairment (MCI) were diagnosed, with 91 (61%)
participants not meeting criteria for dementia or MCI (non-
cases). 
Six of the 11 participants who were diagnosed with
dementia agreed to have blood tests performed, and no
abnormalities were detected apart from elevated blood
glucose in two participants who were known sufferers of
diabetes mellitus. Of the 11 participants, four new CT scans,
one previously done CT and one previously done MRI scan
were reviewed with all scans revealing evidence of vascular
pathology in the brain, with evidence of old infarcts in three of
the CT scans.
Of the 38 cases of MCI, 18(47.4%) represented amnestic
MCI, single domain (aMCIsd), 12 (31.6 %) were amnestic MCI,
multi-domain (aMCImd) and 8 (21.0 %) were non-amnestic
MCI single domain (naMCIsd). No cases of non-amnestic MCI
multiple domain (naMCImd) were identified. No cases of
delirium were identified and thirteen participants (9.3%) were
diagnosed with major depression.
The 91 non-cases comprised a mixture of participants with
varying degrees of cognitive and functional impairment.
Impairment in executive functioning was present in 28 (30.8 %)
and memory impairment in 36 (39.6%) of these participants.
Twenty of the 91(22.0%) would have met the criteria for MCI
but were significantly functionally impaired in at least one
instrumental activity of daily living domain and were therefore
excluded; 17 of the 91(18.7%) who were functionally impaired
failed to meet the cognitive impairment criteria for dementia. 
Risk factor profile
To establish a risk profile, the prevalence of clinical factors was
determined for each diagnostic category and compared to
‘non-cases’ (Table II). 
A number of significant associations between risk factors
and diagnostic categories were found. Firstly, there were
significant associations between the diagnostic groups and
self-reported “blackouts” (transient periods of loss of
consciousness for which a medical diagnosis had not been
established at the time of assessment). Only 8.8% of non-cases
reported a history of blackouts compared to 27.3% of
participants with dementia and 26.3% of participants with MCI
(p=.012). 
Secondly, a significant negative association was found
between reported high blood pressure and cognitive
impairment (dementia and MCI). Seventy three point six
percent of non-cases reported a history of high blood pressure
compared to 36.4% of participants with dementia and 57.9% of
participants with MCI (p=.024). 
Thirdly, a significant association with exercise was found
with participants with dementia reporting more engagement in
Table I: Demographics according to Diagnostic Categories
Item Dementia MCI Non-cases Statistic P
(n=11) (n=38) (n=91) 
n (%) n (%) n (%)
Race 
Asian 0 (0%) 6 (15.8%) 22 (24.2%) X2=15.0 .078
Black 1 (9.1%) 2 (5.3%) 3 (3.3%)
Coloured 1(9.1%) 15(39.5%) 25 (27.5%)
White 9 (81.8%) 15 (39.5%) 41 (45.1%)
Gender
Female 9 (81.8%) 30 (78.9%) 58(63.7%) X2=3.7 .165
Male 2 (18.2%) 8 (21.1%) 33 (36.3%)
Age 77.2 ± 7.9 75.8 ±8.1 72.1 ±6.8 K=7.9 .020*
Years of education 10.3 ±2.6 9.3 ±1.6 10.3 ±2.1 K=6.6 .036*
Age and Years of Education were compared using Independent Samples Kruskal-Wallis or Fisher Exact Tests. Gender and Race was compared using
Pearson Chi-square Tests. *Significance level set as p< .05.
Table II: Presence of Risk Factors within Diagnostic Categories
Dementia MCI Non-cases  Total X2 P Value
(n=11) (n=38) (N=91) (n=140)
Vascular Risk Factors
Stroke 4 (36.4 %) 6 (15.8 %) 10 (11 %) 20 (14.3 %) X2=4.8 .065
Blackouts 3 (27.3 %) 10 (26.3 %) 8 (8.8 %) 21 (15 %) X2=8.0 .012*
High Cholesterol 3 (27.3 %) 11 (28.9 %) 30 (33 %) 44 (31.4 %) X2=0.3 .879
High blood pressure 4 (36.4 %) 22 (57.9 %) 67 (73.6 %) 93 (66.4 %) X2=7.8 .024*
Heart attack 0 (0 %) 5 (13.2 %) 21 (23.1 %) 26 (18.6 %) X2=4.1 .117
IHD/Angina 3 (27.3 %) 12 (31.6 %) 22 (24.2 %) 37 (26.4 %) X2=0.9 .649
Modified Hachinski score category >=5 3 (27.3 %) 3 (7.9 %) 7 (7.7 %) 13 (9.3 %) X2=4.5 .120
Lifestyle Risk Factors
Cigarettes Current or Past 8 (72.7 %) 24 (63.2 %) 75 (82.4 %) 107 (76.4 %) X2=1.7 .795
Alcohol Current or Past 7 (63.6 %) 18 (47.4 %) 35 (38.5 %) 60 (42.9 %) X2=0.5 .833
Engages in any exercise 6(54.5%) 6 (15.8%) 22 (24.2%) 34(24.3%) X2=7.0 .031*
Psychological Risk Factors
MDD Current 1 (9.1 %) 2 (5.3 %) 10 (11 %) 13 (9.3 %) X2=1.0 .646
MDD Past 2 (18.2 %) 12 (31.6 %) 24 (26.4 %) 38 (27.1 %) X2=.8 .719
#Presence of at least one Subjective 
Memory Complaint (SMCC) 10 (90.9 %) 38 (100 %) 32 (35.2 %) 80 (57.1 %) X2=51.6 .001*
Other Risk Factors
Family Dementia 0 (0 %) 4 (10.5 %) 7 (7.7 %) 11 (7.9 %) X2=1.3 .687
Head injury 1 (9.1 %) 9 (23.7 %) 16 (17.6 %) 26 (18.6 %) X2=1.2 .535
Diabetes Mellitus 4 (36.4 %) 8 (21.1 %) 25 (27.5 %) 37 (26.4 %) X2=1.2 .530
All risk factors were compared using Independent Samples Pearson Chi-square Tests and Fisher Exact Tests. *Significance level set as p < .05. #SMCC
was defined for a specified minimum duration (previous one year), frequency (at least once a week) and sub-type (memory for names, places, events).
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physical exercise (54.5%) compared to participants with MCI
(15.8%) and non-cases (24.2%; p=.012). 
Lastly, there was a significant association between the
presence of a subjective memory complaint assessed clinically
(SMCC) and the presence of dementia. Ninety point nine
percent of participants with dementia compared to 35.2% of
non-cases (p<.001) reported the presence of an SMCC.
(SMCC is a diagnostic criterion for MCI). The presence of a
SMCC was not significantly associated with the presence of
major depression(X2=0.86, p=.355). 
Physical and functional impairment profile
In addition to clinical risk factors, the presence of physical
impairment (Table III) and the capacity to perform instrumental
activities of daily living (Table IV) and diagnostic categories
were also compared. Two significant associations were found
between physical impairments and diagnostic groupings
(Table III). 
In terms of visual impairments, more participants with MCI
reported visual impairments (92.1%) as compared to
participants with dementia (54.5 p=.019). More participants
with dementia (45.5%) and MCI (47.4%) also reported hearing
impairments as compared to non-cases. (25.3%; p=.036). 
The ability to perform ADLs and IADLs have diagnostic
significance for dementia. In evaluating the functional profile of
participants, significant differences were found between
dementia, MCI and non-cases for the following activities: Use of
public transport, meal preparation, taking medication,
Table III: Presence of Physical Impairments within Diagnostic Categories
Dementia MCI Non-cases  Total X2 P Value
(n=11) (n=38) (N=91) (n=140)
Uses walking aid 4 (36.4 %) 11 (28.9 %) 23 (25.3 %) 38 (27.1 %) X2=0.7 .686
Visual problems 6 (54.5 %) 35 (92.1 %) 72 (79.1 %) 113 (80.7 %) X2=7.8 .019*
Use of visual aids 6 (54.5 %) 33 (86.8 %) 77 (84.6 %) 116 (82.9 %) X2=5.7 .051
Hearing problems 5 (45.5 %) 18 (47.4 %) 23 (25.3 %) 46 (32.9 %) X2=6.8 .036*
Use of hearing aids 2 (18.2 %) 1 (2.6 %) 5 (5.5 %) 8 (5.7 %) X2=3.4 .178
All risk factors were compared using Independent Samples Pearson Chi-square Tests and Fisher Exact Tests. *Significance level set as p < .05. #SMCC
was defined for a specified minimum duration (previous one year), frequency (at least once a week) and sub-type (memory for names, places, events).
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shopping, and using the microwave and washing machine
(Table IV). All participants reported being able to use a radio.
Discussion
Prevalence of Dementia and MCI
Dementia prevalence: The study identified a dementia
prevalence of 7.9%, similar to prevalence rates reported in
homogeneous South African populations (8.6%14 and 7.7%15)
but greater than the mean age-adjusted prevalence estimate
for dementia in LAMIC of 5.3%.3 The range of prevalence
figures in Africa could be attributed to differences in population
age structures, genetics and lifestyle3, but could also be due to
methodological factors in the assessment and assignment of a
diagnosis. Methodological factors may include variations in the
use of accurate, standardised diagnostic measures and
variations in clinical opinion of what constitutes ‘significant’
impairment in social and occupational functioning.
‘Impairment’ also varies according to cultural expectations of
the elderly with regard to their functional activities and hence
influences the definition of ‘functional impairment’ in different
socio-cultural settings.3
While our prevalence figure lies within the range reported
for LAMIC countries, our sample is drawn from a residential,
not a community or a nursing home setting . International
prevalence figures for dementia in elderly residential homes
vary from 36.7%-58%.19,27,20,21,22 Prevalence figures vary
according to the admission criteria and the heterogeneity in
the types of residential facilities and data from LAMIC are
scarce. In the United Kingdom, where almost 5% of people
aged 65 years or older live in institutions, two thirds of the
elderly in residential homes23 and 62% of the elderly residing
in private and council residential and nursing homes were
found to have dementia.24 The prevalence of dementia in
Mexican nursing homes is 16.1%.25,27
An important factor emerging from our study was that none
of these residents had been previously diagnosed with
dementia or MCI. The under-recognition of dementia is not
unique to our setting as rates of under-recognition range from
31.8%21 for dementia in Scotland to 70% for mild dementia in
Hong Kong.20 Our findings therefore identify a need for
increasing the awareness of dementia among the personnel
working in residential settings for the elderly. 
A limitation in our findings has been the exclusion of those
unable or too impaired to engage consensually in the
assessment procedures and this may have contributed to the
relatively low prevalence of dementia of 7.9% in our study.
Further large scale community studies are needed to confirm
the prevalence of dementia in South Africa.
MCI prevalence: MCI was diagnosed in 27% of our sample,
which is similar to the prevalence rates of 3% to 42%26 reported
in the literature. The wide range has been attributed to the lack
of standardization of the definition and diagnostic criteria of
MCI.26 Diagnostic consistency across studies will assist in
establishing the true burden posed by MCI in the elderly. This
is important as the reported annual conversion rate of MCI to
Alzheimer’s dementia is 10-15%27 in high risk clinical
populations and 4.2% in the general population.28
Despite existing diagnostic criteria for MCI27,29, the lack of
appropriate and sensitive neuropsychological and functional
measures30 poses challenges to its consistent application and
interpretation. Challenges in assigning this diagnosis include
the fact that subjective memory deficits lack clear definition31,
and the interpretation of what constitutes ‘minimal’ impairment
in IADL in the context of MCI. This is important as it has been
shown that impairment in IADL impacts significantly on the
prognostic value of MCI with respect to progression to
dementia.32-35 Delaying the progression of MCI to dementia by
one year will result in significant cost savings36, therefore
objective measurement criteria for MCI and IADL are essential. 
The most prevalent subtypes of MCI in our study was
aMCIsd (47.4%) followed by aMCImd (31.6%). The risk of
converting to dementia is increased when cognitive domains in
addition to memory (multi-domain) are impaired.37 Those with
single domain MCI are reported to revert to normal cognitive
functioning with greater frequency than those with multi-
domain impairment.28 This places almost a third of those
diagnosed with MCI in our sample at high risk for progressing
to dementia and targets them for close monitoring. However,
although MCI subtypes have diagnostic validity and clinical
utility38,28, MCI is a heterogeneous condition39 both
aetiologically and prognostically and the clinical significance of
these subtypes are best evaluated in a prospective study. 
Challenges in the evaluation of cognition: The evaluation of
cognition in the elderly, especially in in LAMICs, is
compounded by numerous practical and technical issues.40,41 A
major challenge is the validity and sensitivity of the diagnostic
criteria applied. Diagnostic criteria should help to clearly
distinguish normal from pathological cognitive impairment.
Table IV: Retained Functionality in IADL 
Dementia MCI Non-cases  Total X2 P Value
(n=11) (n=38) (N=91) (n=140)
Telephone use 10(90.9%) 38 (100%) 88 (96.7%) 136 (97.1%) X2=2.7 .225
Public transport (*NA=15) 4(40%) 33 (100%) 78 (95.1%) 115 (89.3%) X2=22.3 <.001*
Meal preparation (NA=7) 8 (80%) 34 (97.1%) 87 (98.9%) 129 (92.1%) X2=7.0 .024*
Operating TV (NA=3) 10(90.9%) 35 (100%) 91 (100%) 136 (97.1%) X2=5.7 .080
Operating microwave (NA=5) 7(70%) 36 (94.7%) 85 (97.7%) 128 (91.4%) X2=9.0 .010*
Operating washing machine) (NA=8) 7(70%) 34 (94.4%) 83 (96.5%) 124 (88.6%) X2=7.6 .016*
Taking medication (NA=7) 5 (55.6%) 38 (100%) 80 (93%) 123 (87.9%) X2=13.6 <.001*
Shopping (NA=3) 7 (63.6%) 37 (100%) 84 (94.4%) 128 (91.4%) X2=12.1 .002*
IADL were compared using Independent samples Pearson Chi-square Tests and Fisher Exact Tests. *Significance level set as p < .05.
*NA=Data either not available or not-applicable 
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While ninety one participants in our study did not meet the
criteria for dementia or MCI, they were found to have varying
levels of cognitive and functional deficits. Cognitive impairment
in the elderly exists on a continuum ranging from normal,
subjective cognitive impairment (pre-MCI)42, MCI to dementia.
In addition, impairment in multiple cognitive domains are
present many years before a diagnosis of dementia (AD) is
made.43 Even though the DSM criteria are widely used, the
ICD-10 sets a higher threshold for dementia compared to
DSM-III-R44 and a ten-fold difference in the rate of dementia
diagnosis using six separate classification systems has been
demonstrated.45 The literature has been criticised for failing to
provide clear guidance on standards against which functional
and cognitive impairments should be measured.32 Current
diagnostic criteria define a ‘narrow category of unambiguous
dementia characterised by marked impairment’.46 The
limitations of the current DSM IV-TR diagnostic system has the
potential to under-estimate the prevalence of dementia with
significant socio-clinical implications.47
Similar diagnostic challenges are encountered with MCI
diagnosis. Different definitions of MCI have been shown to
significantly influence the annual conversion rates from MCI to
dementia.17 MCI diagnosis requires the demonstration of the
‘preservation of independence in functional abilities.’ While
abilities may appear to be overtly preserved, subtle
impairments related to time and precision may be present that
are not readily measurable29 and could still impact on the
autonomy of individuals. In addition, consensus is required on
the level of impairment in IADL that distinguishes MCI from
dementia and normal ageing.33 These issues have significant
clinical and ethical implications for clinicians, patients and their
families. 
Risk factors and dementia
The prevalence of several clinical risk factors for cognitive
impairment in our sample, compounded by the low level of
protective factors, identifies this population as a vulnerable
group in need of preventative interventions.
Demographic risk factors: In keeping with the literature,
there was a progressive and statistically significant (p =.020)
increase in the mean age of participants from the MCI to
Dementia categories in our study. The results also suggest an
increasing progression of cognitive impairment with age.
Increasing age has been identified as the ‘most consistent risk
factor for dementia worldwide’3,48 and for dementia in LAMIC
countries.9,49,50,51
In terms of gender, in our study, there were more than twice
as many female participants (97 females, 43 males), and
females were more prevalent in all diagnostic categories but
the differences were non- significant. Our findings are similar to
the Indo-US study52, where the prevalence of dementia was not
associated with gender. Females have been shown to be at
increased risk for dementia in developed regions as well as
Asian countries, but this association was not clear for African
and Latin American countries.3 Hormonal factors have been
implicated in the differential risk of women53, however other
protective factors may exist that are unique to women in
developing countries; identification of such factors could be
useful in reducing the risk to women in developed countries.
We were not able to show an association between race and
the prevalence of cognitive impairment due to the low
representation of Asians, blacks and coloureds in our sample
(Table I). While trends are changing, it is not common local
practice for the elderly to be placed in old-age homes,
especially among Asian and black families, which may account
for the low representation in our sample. Nigerian Africans
have been found to have a lower prevalence of AD compared
to their American-African counterparts.8 While different
environmental risk factors may be implicated54, the clinical and
molecular aetiologies of dementia have been found to differ
among races55 contributing to racial differences in risk for the
various types of dementia. It is therefore necessary for local
studies to be conducted to establish the risk profile of the
different race groups in South Africa.
Lastly, education is said to be protective against dementia
through its contribution to cognitive reserve56 and our results
indicated a significant difference in years of education between
the MCI group compared to the dementia group. However,
years of education may not be a sensitive measure of education
in our sample where there are discrepancies in the quality of
education received by different race groups. Two strategies are
suggested to deal with education in this context, namely the
use of literacy as a marker and the use of informants for
screening of dementia. Literacy has been proposed as a more
accurate measure of education.57 African Americans performed
significantly lower than White Non-Hispanics on several
cognitive tests despite controlling for demographics and years
of education. These differences in performance disappeared
after controlling for literacy levels58, highlighting the
importance of accommodating for education effects when
interpreting test results. It may be useful for local researchers
to measure literacy as part of the assessment of dementia in
future. The second strategy of using informant surveys may
offer an opportunity to overcome the challenges posed in
assessments due to differences in educational level. The use of
informants in cognitive evaluations has been shown in different
cultures to be as effective as cognitive assessments and has the
advantage of not being biased by educational level.59,60
Unfortunately in our studywe did not have access to informants. 
Clinical risk factors: Described as a ‘tidal wave on the
horizon61, dementia in LAMICs has been shown to be the most
important independent contributor to disability in the elderly.62
In the absence of specific treatment, attention has to be
focussed on identifying and modifying risk factors. Optimum
and aggressive control of hypertension, diabetes, weight,
smoking, and vascular risk factors and the need for exercise
have been identified as potential preventative strategies.63,64
Vascular dementia accounts for about 30% of the total
dementia prevalence.3 Vascular risk factors were most
prevalent in our study. The history of a stroke among the
dementia cases (36.4%) was high even though this did not
reach statistical significance. There was also radiological
evidence of vascular pathology in all six of the dementia
participants for whom scans were available, three of whom had
evidence of infarcts. Temporality was not established in our
study, but it is known that 10% of patients develop dementia
after a first stroke and a third after recurrent stroke.65 The acute
stroke patient of today, may be the dementia referral of
tomorrow. There is therefore a need for stroke neurologists and
cognitive physicians to work more closely63, to ensure optimum
management of this high risk population and early detection of
cognitive impairment.
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Hypertension was present in 66.4% of the participants:
36.4% in dementia, 57.9% in MCI and 73.6% in the non-case
group, p=.024. This represents a high burden and raises
concern as hypertension has been associated with an
increased risk of cognitive decline and dementia29,66,67,3 as well
as a higher rate of progression from MCI to dementia.58 While
there is no compelling evidence that dementia can be
prevented by modifying vascular risk factors68, a more
complete understanding of the pathophysiology, and aetiology
of dementia, especially in different population groups3,68,69, will
serve to better inform clinicians. Optimum management of
vascular disease is nonetheless necessary for healthy ageing.68
Diabetes, also shown to increase the risk of dementia in the
elderly70-60, was not significantly more prevalent in the dementia
group compared to the MCI and ‘non-case’ groups. 36.5%,
212.1%, 27.5%; p=.530). However, low dementia case numbers
(<4) also prevent us identifying diabetes as being associated
with dementia in our sample. A fifth (21.1%) of those diagnosed
with MCI in our study had diabetes mellitus, identifying them at
higher risk, as diabetes has been shown to substantially
increase the progression from MCI to dementia.71
Physical and mental exercise, social engagement, and
nutrition and stress management are important factors in
maintaining cognitive vitality and protecting against the
development of dementia.72 A comprehensive review of the
evidence has also confirmed the negative impact of social
isolation and the protective effect of exercise on cognitive
health.73 Of concern in our study was the fact that the
participants were found to be physically inactive with less than
a quarter of participants engaging in any physical exercise.
Given the significant medical implications of a sedentary life,
this is an important and simple intervention that can reduce
risk for both physical and cognitive decline. 
Subjective memory complaints: More than 50% of our
sample reported the presence of a subjective memory
complaint. A significant association was found between the
presence of a SMC and the presence of dementia (X2=51.6,
p=.001). In our study, a SMC was present in 90.9% of those
diagnosed with dementia. The prevalence of SMC in the
community varies from 25-50%74 and is present in 42.8% of
dementia sufferers and 38.2% with MCI.75 As with any
subjective measure, assessing for the presence of SMCs poses
challenges. The lack of standardisation of the definition of
SMCs across studies complicates the interpretation of results
as31 different criteria may refer to different underlying cognitive
constructs. However, the presence of SMC has been associated
with cerebral white matter lesions in the absence of objective
cognitive impairment76, implying that they may have diagnostic
validity. The diagnosis of SMC should therefore be
standardised based on criteria that include age and nature of
onset, course, duration and frequency.31 This may result in
better correlation between subjective and objective measures
of disease and improve the validity and predictive value of
SMCs for dementia.
The mean number of memory complaints per participant in
our study increased significantly with increasing cognitive
impairment from MCI to Dementia (p=.001). The presence of
subjective memory complaints (SMC), also referred to as
subjective memory impairment (SMI), and subjective cognitive
impairment (SCI), is regarded as a pre-MCI stage which has a
mean duration of 15 years.42 Elderly individuals with SMC may
be at a fourfold increase of dementia or a two fold increase of
depression.77 However, an association between SMC and
depression, past or current, was not found in our study. 
The utility index of SMC has recently been assessed as
‘good’ for ruling out a diagnosis of dementia but ‘poor’ for
ruling in a diagnosis of dementia as there is only a 20%-30%
chance of dementia or MCI being present in those with SMC.75
However, there is evidence for its use in brief screening
programmes.75 In the local context of a severe shortage of
mental health professionals78, further evaluation of the clinical
correlates and utility of SMCs may clarify its potential as a
simple, cost-effective screening measure towards meeting the
challenges associated with the predicted upsurge in the
prevalence of dementia.
Functional assessments: A diagnosis of dementia requires
the confirmation of cognitive decline of sufficient severity to
cause functional impairment. The concise definition of the
functional status of patients is necessary for optimum care
planning79 as greater impairment has been associated with
earlier institutionalization, decreased quality of life, death,
increased caregiver burden, and increased health and care
costs.80
In the current study, the preservation of activities of daily
living (IADL) functions in the dementia category ranged from
40% for the independent use of public transport to 90.9% for
the use of a telephone. With the exception of the ability to use a
telephone and the television, preservation of functionality in the
remaining IADL domains assessed significantly distinguished
those with dementia from those without (Table III). In our
sample, the use of the telephone was an ability that was best
preserved amongst all diagnostic categories, suggesting that
this might be an ability that is relatively resistant to
deterioration. Inter-task difference analyses have revealed that
finances, meal preparation, housekeeping and shopping are
the earliest functions to deteriorate, while telephone use
appeared to be more resistant.80 Loss of skills related to
independent medication management, shopping,
housekeeping and use of public transport have also been
shown to significantly impact on time to incident dementia.35
In LAMIC, where low education levels are more prevalent
than in HIC, screening tools with minimal education bias are
necessary. Cognitive decline contributes to functional
impairment and is expressed among instrumental activities
before basic activities of daily living.80 IADL require a high
degree of executive skills and executive dysfunction has been
correlated with IADL disability.79 Functional scales therefore
have the potential to be used as screening tools, and have less
education bias than cognitive tests.81 Several IADL scales are in
use and even though their psychometric properties need to be
further established82, they have been shown to discriminate
between the demented and non-demented as well as detect
mild dementia with minimum effects of age, gender and
education.81
IADL scales have been shown to be ‘reliable, sensitive and
responsive’ and useful in dementia screening in a
heterogeneous Indian population83, with acceptable efficiency
for dementia screening.84 They have been shown to compare
favourably against the MMSE when administered by General
Practitioners and have the advantage of being simple and non-
threatening to administer.85
It has been shown that subjects who performed poorly on
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IADL were more likely to develop dementia ten years later.33
IADL assessments are useful as diagnostic aids in memory
clinics, and are able to predict the onset of dementia at one and
two year follow-up.86 IADL assessments also have the potential
to distinguish between clinical stages along the continuum from
subjective to objective cognitive impairment. Specific areas of
IADL impairment show discriminative and predictive power for
Subjective Cognitive Impairment (SCI) and MCI.87 The
inclusion of IADL impairment in the diagnosis of MCI has been
shown to significantly improve dementia prediction in those
who have MCI.35 These findings support the need for the
further evaluation of IADL scales as screening tools for
dementia in the local setting especially as they require low skill
in administration. The limitations of IADL scales can be
addressed by enhancing self-report through collateral
corroboration86, standardizing performance-based
assessments that include measures of accuracy and speed35,
and improving the psychometric properties by establishing
validity.
Limitations
While this study provides useful information on the
demographic and risk profile of a heterogeneous South African
elderly population, the nature of the sample and its small size,
the low numbers of black participants, and the low number of
dementia cases limit the generalizability of our findings. Inter-
rater reliability should have been formally quantified. The study
is however useful in defining the risk profile of this elderly
population and provides a platform for the introduction of risk
management interventions.
Conclusion
The quantification of the prevalence of cognitive impairment in
a non-clinical sample highlights its under-recognition locally.
The prevalent risk factors call for increasing the awareness of
dementia in the general population combined with active
medical outreach to non-clinical populations. The reported
lower prevalence of dementia in LAMIC highlights the need for
risk factors as well as ‘protective’ social and contextual
determinants of health and dementia, the ‘new epidemiology’88,
to be studied. Dementia in LAMICs deserve further
epidemiological research to address the growing burden89,
better define risks and devise novel approaches to prevention,
early detection and adequate treatment.33
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